Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease
•CD70+ receptor is a marker of T cell activation during inflammatory bowel disease.•CD70+ T cells was significantly reduced by treatment with anti-TNFα antibodies.•CD3+ T cells were increased in anti-TNFα treated compared to untreated patients.•Relation between the drug behaviour and the lymphocytes...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2021-11, Vol.100, p.108081-108081, Article 108081 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!